Trials / Sponsors / Pharma Holdings AS
Pharma Holdings AS
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococc Nasal Decolonization of Staphylococcus Aureus | Phase 2 | 2022-09-19 |
| Unknown | Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. COVID-19 | Phase 2 | 2021-05-03 |
| Completed | LTX-109 as Treatment for Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 1 / Phase 2 | 2021-03-05 |
| Completed | A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Nasal Decolonization of Staphylococcus Aureus | Phase 1 / Phase 2 | 2021-02-22 |